Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ligong Lu

Showing results (31-40 of 175) with videos related to

Pageof 18
Sort By:
Frontiers in Pharmacology|March 9, 2023
Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinomaLei Jiang, Luan Li, Yongzhuang Liu, et al.
World Journal of Surgical Oncology|February 18, 2022
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cellsXiaoying Hou, Cong Du, Ligong Lu, et al.
Oncotarget|February 25, 2016
Computed tomography texture analysis to facilitate therapeutic decision making in hepatocellular carcinomaMeng Li, Sirui Fu, Yanjie Zhu, et al.
Oncotarget|December 3, 2016
Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients' selection of transcatheter arterial chemoembolization and sorafenibSirui Fu, Shuting Chen, Changhong Liang, et al.
Acta Pharmaceutica Sinica. B|March 1, 2021
Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug deliveryShaojun Peng, Boshu Ouyang, Yongjie Xin, et al.
Cell Death & Disease|February 26, 2024
SPOP point mutations regulate substrate preference and affect its functionYanran Deng, Wenhao Ding, Kaize Ma, et al.
Cancer Letters|July 23, 2022
CD155 in tumor progression and targeted therapyMeixiao Zhan, Zhiren Zhang, Xiaoguang Zhao, et al.
Drug Design, Development and Therapy|July 30, 2019
Effect of loading dose of atorvastatin therapy prior to percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of six randomized controlled trialsMingfeng Ma, Lixia Bu, Li Shi, et al.
Nature Communications|May 30, 2023
Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenaseMeixiao Zhan, Yufeng Ding, Shanzhou Huang, et al.
Frontiers in Bioengineering and Biotechnology|March 18, 2024
Cancer diagnosis and treatment platform based on manganese-based nanomaterialsJia Fei, Yanyan Liu, Ya Zeng, et al.
Pageof 18

Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
Frontiers in Pharmacology|March 9, 2023
Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinomaLei Jiang, Luan Li, Yongzhuang Liu, et al.
World Journal of Surgical Oncology|February 18, 2022
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cellsXiaoying Hou, Cong Du, Ligong Lu, et al.
Oncotarget|February 25, 2016
Computed tomography texture analysis to facilitate therapeutic decision making in hepatocellular carcinomaMeng Li, Sirui Fu, Yanjie Zhu, et al.
Oncotarget|December 3, 2016
Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients' selection of transcatheter arterial chemoembolization and sorafenibSirui Fu, Shuting Chen, Changhong Liang, et al.
Acta Pharmaceutica Sinica. B|March 1, 2021
Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug deliveryShaojun Peng, Boshu Ouyang, Yongjie Xin, et al.
Cell Death & Disease|February 26, 2024
SPOP point mutations regulate substrate preference and affect its functionYanran Deng, Wenhao Ding, Kaize Ma, et al.
Cancer Letters|July 23, 2022
CD155 in tumor progression and targeted therapyMeixiao Zhan, Zhiren Zhang, Xiaoguang Zhao, et al.
Drug Design, Development and Therapy|July 30, 2019
Effect of loading dose of atorvastatin therapy prior to percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of six randomized controlled trialsMingfeng Ma, Lixia Bu, Li Shi, et al.
Nature Communications|May 30, 2023
Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenaseMeixiao Zhan, Yufeng Ding, Shanzhou Huang, et al.
Frontiers in Bioengineering and Biotechnology|March 18, 2024
Cancer diagnosis and treatment platform based on manganese-based nanomaterialsJia Fei, Yanyan Liu, Ya Zeng, et al.
Pageof 18